The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol-and drospirenone-containing oral contraceptive

European Journal of Contraception and Reproductive Health Care

Volumn 18, Issue 6, 2013, Pages 489-500

  Zimmerman, Yvette ^a   Coelingh Bennink, Herjan J T ^a   Wouters, Wout ^a   Ebes, Frieda ^b   Fauser, Bart C J M ^c  

^a Pantarhei Bioscience   (Netherlands)

^b SYNEOS HEALTH   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Androgens; DHEA; DHEA S; Oral contraception; Pharmacokinetics; Testosterone

Indexed keywords

ALBUMIN; DROSPIRENONE; ESTRADIOL; ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT; PRASTERONE; PRASTERONE SULFATE; SULFATE; TESTOSTERONE;

ACCURACY; ACNE; ADULT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; FOLLOW UP; HEADACHE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; NAUSEA; NORMAL HUMAN; ORAL CONTRACEPTIVE USE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION;

ADULT; ANALYSIS OF VARIANCE; ANDROSTENES; CONTRACEPTIVES, ORAL, COMBINED; CROSS-OVER STUDIES; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ETHINYL ESTRADIOL; FEMALE; HUMANS; LEVONORGESTREL; PREGNANCY; PROSPECTIVE STUDIES; TESTOSTERONE;

EID: 84887913015     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.3109/13625187.2013.822061     Document Type: Article

References (41)

1. Fern M, Rose D, Fern E. Effect of oral contraceptives on plasma androgenic steroids and their precursors. Obstet Gynecol 1978; 51: 541-4.
2. Aden U, Jung-Hoffmann C, Kuhl H. A randomized crossover study on various hormonal parameters of two tripha-sic oral contraceptives. Contraception 1998; 58: 75-81.
3. Wiegratz I, Kutschera E, Lee J, et al. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins. Contraception 2003; 67: 25-32.
4. Ågren UM, Anttila M, Mäepää-Liukko K, et al. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 ß-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function. Eur J Contracept Reprod Health Care 2011; 16: 458-67.
5. Van der Vange N, Blankenstein M, Kloosterboer H, et al. Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone. Contraception 1990; 41: 345-52.
6. Coenen C, Thomas C, Borm G, et al. Changes in andro-gens during treatment with four low-dose contraceptives. Contraception 1996; 53: 171-6.
7. Greco T, Graham C, Bancroft J, et al. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: A comparison of two triphasic formulations containing norgestimate and either 35 or 25 μ g of ethinyl estradiol. Contraception 2007; 76: 8-17.
8. Bachmann G, Bancroft J, Braunstein G, et al. Female androgen insufficiency: The Princeton consensus statement on definition, classification, and assessment. Fertil Steril 2002; 77: 660-5.
9. Traish A, Guay A, Spark R, the Testosterone Therapy in Women Study Group. Are the Endocrine Society's clinical practice guidelines on androgen therapy in women misguided? A commentary. J Sex Med 2007; 4: 1223-35.
10. Arlt W, Justl H-G, Callies F, et al. Oral dehydroepiandros-terone for adrenal androgen replacement: Pharmacoki-netics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 1998; 83: 1928-34.
11. Morales A, Nolan J, Nelson J, Yen S. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994; 78: 1360-7.
12. Legrain S, Massien C, Lahlou N, et al. Dehydroepian-drosterone replacement administration: Pharmacoki-netic and pharmacodynamic studies in healthy elderly subjects. J Clin Endocrinol Metab 2000; 85: 3208-17.
13. Meno-Tetang G, Blum R, Schwartz K, Jusko W. Effects of oral prasterone (dehydroepiandrosterone) on single-dose pharmacokinetics or oral prednisone and cortisol suppression in normal women. J Clin Pharmacol 2001; 41: 1195-205.
14. Zimmerman Y, Wouters W, Coelingh Bennink HJT. The bioequivalence of the contraceptive steroids ethinylestradiol and drospirenone is not affected by co-administration of DHEA. Eur J Contracept Reprod Health Care 2013; 18: 206-14.
15. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666-72.
16. de Ronde W, van der Schouw YT, Pols HAP, et al. Calculation of bioavailable and free testosterone in men: A comparison of 5 published algorithms. Clin Chem 2006; 52: 1777-84.
17. Rinaldi S, Geay A, Déchaud H, et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 2002; 11: 1065-71.
18. Miller KK, Rosner W, Lee H, et al. Measurement of free testosterone in normal women and women with androgen deficiency: Compar ison of methods. J Clin Endocrinol Metab 2004; 89: 525-33.
19. Parasrampuria J, Schwartz K, Petesch R. Quality control of dehydroepiandrosterone dietary supplement products. JAMA 1998; 280: 1565.
20. Baulieu E-E, Thomas G, Legrain S, et al. Dehydroepian-drosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge Study to a sociobiomedical issue. PNAS 2000; 97: 4279-84.
21. Odlind V, Milson I, Persson I, Victor A. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstet Gynecol Scand 2002; 81: 482-90.
22. Carlström K, Karlsson R, Von Schoultz B. Diurnal rhythm and effects of oral contraceptives on serum dehydroepiandrosterone sulfate (DHEAS) are related to alterations in serum albumin rather than to changes in adrenocortical steroid secretion. Scand J Clin Lab Invest 2002; 62: 361-8.
23. Hucklebridge F, Hussain T, Evans P, Clow A. The diurnal patterns of the adrenal steroids cortisol and dehydroepiandrosterone (DHEA) in relation to awakening. Psychoneuroendocrinology 2005; 30: 51-7.
24. Matchock RL, Dorn LD, Susman EJ. Diurnal and seasonal cortisol, testosterone, and DHEA rhythms in boys and girls dur ing puberty. Chronobiol Int 2007; 24: 969-90.
25. Madden JD, Milewich L, Parker CR Jr., et al. The effect of oral contraceptive treatment on the serum concentration of dehydroisoandrosterone sulfate. Am J Obstet Gynecol 1978; 132: 380-4.
26. Nicolau GY, Haus E, Lakatua DJ, et al. Circadian and circannual variations on FSH, LH, testosterone, dehy-droepiandrosterone-sulfate (DHEA-S) and 17-hydroxy progesterone (17 OH-Prog) in elderly men and women. Endocrinologie 1985; 23: 223-46.
27. Mikulecky M, Kreze A, Putz Z, Moravcik M. Daily variation of serum cortisol, 17-hydroxyprogesterone and five androgens in healthy women. Braz J Med Biol Res 1995; 28: 485-90.
28. Hammer F, Subtil S, Lux P, et al. No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: In vivo and in vitro studies. J Clin Endocrinol Metab 2005; 90: 3600-5.
29. Murphy AA, Cropp CS, Smith BS, et al. Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women. Fertil Steril 1990; 53: 35-9.
30. Wiegratz I, Jung-Hoffmann C, Kuhl H. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and ser um binding proteins. Contraception 1995; 51: 341-6.
31. Carr BR, Parker CR Jr., Madden JD, et al. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment. J Clin Endocrinol Metab 1979; 49: 346-9.
32. Klove KL, Roy S, Lobo RA. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate. Contraception 1984; 29: 319-24.
33. Dyner TS, Lang W, Geaga J, et al. An open-label dose-escalation trial of oral dehydroepiandrosterone tolerance and pharmacokinetics in patients with HIV disease. J Acquir Immune Defic Syndr 1993; 6: 459-65.
34. Duijkers I, Klipping C, Grob P, Korver T. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 ß-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol. Eur J Contracept Reprod Health Care 2010; 15: 314-25.
35. Blode H, Wuttke W, Loock W, et al. A 1-year pharma-cokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers. Eur J Contracept Reprod Health Care 2000; 5: 256-64.
36. Zimmerman Y, Coelingh Bennink HJT. Clinical effects of normalizing testosterone levels during oral contraception. Ferti Steril 2012; 98(3, Suppl.): S198.
37. van der Spuy ZM, Sohnius U, Pienaar CA, Schall R. Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users. Contraception 1990; 42: 597-609.
38. Nair KS, Rizza RA, O'Brien P, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006; 355: 1647-59.
39. Weiss EP, Shah K, Fontana L, et al. Dehydroepiandros-terone replacement therapy in older adults: 1-and 2-y effects on bone. Am J Clin Nutr 2009; 89: 1459-67.
40. Alkatib AA, Cosma M, Elamin MB, et al. A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency. J Clin Endocrinol Metab 2009; 94: 3676-81.
41. Davis SR, Panjari M, Stanczyk FZ. DHEA replacement for postmenopausal women. J Clin Endocrinol Metab 2011; 96: 1642-53.